What are 2C-B Pills?
2C-B pills are oral tablets containing the synthetic psychedelic compound 2C-B (4-bromo-2,5-dimethoxyphenethylamine). The drug was first synthesized by Alexander Shulgin in 1974 and gained popularity in the 1980s and 1990s, particularly in the Netherlands where it was sold legally under the brand name “Nexus” in smartshops until it was internationally scheduled in 1995.
2C-B produces a complex pharmacological profile often described as a “bridge” between MDMA (empathogenic) and LSD (psychedelic), offering tactile enhancement, emotional openness, colorful visuals, and mild stimulant effects. Pills are the most common form of 2C-B in recreational settings, particularly in Europe and South America.
Chemical Identifiers
| Property | Value |
|---|---|
| IUPAC Name | 4-bromo-2,5-dimethoxyphenethylamine |
| CAS Number | 66142-81-2 |
| Molecular Formula | C10H14BrNO2 |
| Molecular Weight | 260.13 g/mol |
| Pill forms | Pressed tablets, often with logos (e.g., “Nexus”, hearts, stars, geometric shapes) |
Street Names
- Bees
- Nexus (original brand name)
- Venus
- 2C-B
- Bro-mo-spectrum
- Toonies
- Spectrum
- Blue Mystic
Pill Dosages & Potency (Educational Reference Only)
CRITICAL WARNING: 2C-B has a steep dose-response curve. Pills vary widely in actual content (5-25mg+). The difference between a mild experience and an overwhelming one can be just a few milligrams.
| Dose Range (mg) | Effect Level | Typical Experience |
|---|---|---|
| 2-5 mg | Threshold | Barely perceptible; mild mood lift |
| 5-10 mg | Light | Mild mood lift, enhanced sensory perception, subtle visual changes, social lubrication |
| 10-15 mg | Common (entry level) | Moderate visuals (color enhancement, patterns), clear-headed euphoria, tactile enhancement |
| 15-20 mg | Common (standard) | Strong visuals (geometric patterns, tracers), significant euphoria, music enhancement, mild ego softening |
| 20-25 mg | Strong | Intense visuals, time dilation, moderate ego dissolution, potential for challenging experiences |
| 25-30+ mg | Heavy | Very intense, overwhelming for most users, significant confusion, ego dissolution, high risk of difficult experience (“bad trip”) |
Common Pill Logos & Markings (Historical/Educational)
| Pill Logo/Marking | Reported Dosage (approximate) | Notes |
|---|---|---|
| Nexus | 10-20 mg | Original brand name; pills often imprinted with “NEXUS” |
| Hearts | 8-15 mg | Small heart-shaped pills; common in Netherlands in 1990s |
| Stars | 10-20 mg | Star-shaped or star-imprinted pills |
| Mushrooms | 12-18 mg | Mushroom-shaped or imprinted |
WARNING: Pill logos, colors, and shapes are NOT reliable indicators of content. Same logo can contain different drugs and different dosages across different batches. TEST YOUR PILLS.
Duration (Oral Administration)
| Phase | Timing |
|---|---|
| Onset | 45-75 minutes (can be up to 2 hours if taken with food) |
| Come-up | 15-30 minutes (nausea common during this phase) |
| Peak | 2-4 hours |
| Comedown | 1-2 hours |
| Total duration | 4-8 hours (depending on dose and individual metabolism) |
Subjective Effects (Educational Description)
Physical Effects:
- Nausea (especially during come-up — common with oral administration)
- Increased heart rate and mild blood pressure elevation
- Pupil dilation (mydriasis)
- Mild to moderate body temperature increase
- Tactile enhancement (sensations feel more intense)
- Gastrointestinal discomfort (stomach cramps, gas)
- Muscle tension or jaw clenching (milder than MDMA)
- Decreased appetite
Psychological Effects:
- Visual effects: Brightening of colors, geometric patterns, trails, after-images, closed-eye visuals (less intense than LSD or DMT)
- Emotional effects: Euphoria, empathy, emotional openness (milder than MDMA)
- Cognitive effects: Enhanced appreciation of music and art, creative thinking, mild time distortion
- Empathogenic qualities: Increased sense of connection with others, reduced social anxiety
- Stimulant effects: Mild energy boost, talkativeness
Effects by Dose Range
| Dose | Typical Experience |
|---|---|
| 5-10 mg | Mild mood lift, enhanced sensory perception, subtle visual changes, social lubrication, minimal nausea |
| 10-15 mg | Moderate visuals (color enhancement, patterns), clear-headed euphoria, tactile enhancement, good balance of psychedelic and empathogenic effects |
| 15-20 mg | Strong visuals (geometric patterns, tracers), significant euphoria, music enhancement, mild ego softening, increased time dilation |
| 20-25 mg | Intense visuals, time dilation, moderate ego dissolution, potential for challenging experiences, nausea more pronounced |
Health & Safety Risks
Acute Risks:
- Anxiety and panic: 2C-B can cause significant anxiety during come-up, especially at higher doses (15mg+)
- Overstimulation: Uncomfortable physical tension, racing thoughts, agitation
- Nausea/vomiting: Common during come-up, particularly with oral administration and higher doses
- Hypertensive crisis: Rare at typical doses (5-20mg), but risk exists for individuals with pre-existing cardiovascular conditions
- Seizures: Extremely rare, but reported with very high doses (30mg+) or in susceptible individuals
- Psychosis: Can trigger acute psychosis in predisposed individuals (personal or family history of schizophrenia, bipolar disorder)
Long-term Risks:
- HPPD (Hallucinogen Persisting Perception Disorder): Rare but possible with frequent use — persistent visual disturbances (trails, visual snow, halos) long after use
- Persistent psychosis: Extremely rare, primarily in individuals with underlying vulnerability
- Urinary retention: Some users report difficulty urinating during the experience
Drug Interactions
| Drug Class | Interaction | Risk Level |
|---|---|---|
| MAOIs | Dangerous potentiation, hypertensive crisis, serotonin syndrome | High |
| SSRIs/SNRIs | Diminished effects; theoretical serotonin syndrome risk | Moderate |
| Lithium | Increased risk of seizures and psychosis | High |
| MDMA | Additive effects, increased cardiovascular strain, potential for overstimulation | Moderate |
| Alcohol | Increased nausea, impaired judgment, dulled psychedelic effects | Low to Moderate |
| Cannabis | Can intensify effects, increase anxiety, and prolong duration | Moderate |
Contraindications: Personal or family history of psychosis/schizophrenia, uncontrolled hypertension, severe cardiovascular disease, seizure disorders, pregnancy/breastfeeding.
Tolerance & Dependence
- Tolerance: Builds rapidly after a single use (like other psychedelics). Cross-tolerance with LSD, psilocybin, mescaline, and other 2C compounds. Tolerance returns to baseline after 7-14 days.
- Physical dependence: None — no withdrawal syndrome.
- Psychological dependence: Low — not considered addictive. Not associated with compulsive redosing behavior.
Legal Status
| Jurisdiction | Classification | Notes |
|---|---|---|
| United States (federal) | Schedule I | Illegal for possession, sale, distribution (since 1995) |
| United Kingdom | Class A | Up to 7 years imprisonment for possession |
| Canada | Schedule III | Illegal (analogue of controlled phenethylamines) |
| Germany | BtMG Anlage I | Illegal (no medical use) |
| Netherlands | Opium Law (List I) | Illegal (banned in 1997 after being legally sold as “Nexus”) |
| Substance Sold As 2C-B | Risk | |
|---|---|---|
| NBOMe compounds (25I-NBOMe, 25C-NBOMe) | Fatal at milligram doses; bitter/metallic taste vs. 2C-B which is not bitter; overdoses have caused deaths | |
| DOx compounds (DOB, DOC, DOI) | Very long duration (16-24+ hours), higher risk of hypertensive crisis, vasoconstriction | |
| Other 2C compounds (2C-I, 2C-E, 2C-P) | Different potency and duration; some (2C-P) are more potent and longer-lasting | |
| MDMA | Different effects (stronger empathy, less visual); longer duration; different risks (hyponatremia, neurotoxicity) |
| Reagent | 2C-B Reaction | What to Watch For |
|---|---|---|
| Marquis | Yellow → Green | Distinguishes from MDMA (purple-black) and amphetamine (orange) |
| Mecke | No reaction or pale green | Helps rule out NBOMes (green-blue) |
| Froehde | Yellow → Pale green | Confirms 2C-B presence |
| Ehrlich | No reaction | Negative confirms not LSD or tryptamine |
| Recommendation | Rationale | |
|---|---|---|
| Test your pills with reagents | Identify adulterants (NBOMes, DOx, other 2C compounds). Marquis (yellow→green) is key for 2C-B vs. MDMA (purple-black). | |
| Start with half a pill (or less) | Pill potency varies (5-25mg+). Half-pill reduces risk of overdose/unpleasant experience. | |
| Do not redose within 2-3 hours | Delayed onset (45-75 minutes) leads to premature redosing and unintentional high-dose experiences. | |
| Eat lightly 3-4 hours before | Reduces nausea during come-up; heavy meals delay and reduce absorption unpredictably. | |
| Have a sober trip sitter | User may experience confusion or anxiety; someone should be present to call for help if needed. | |
| Use in safe, calm environment | Familiar, comfortable setting reduces anxiety and risk of accidents (crowded clubs/festivals increase risk). | |
| Avoid if personal/family history of psychosis or bipolar disorder | Risk of triggering long-term psychosis or manic episode. Have a lower threshold for anxiety/panic. | |
| Do not mix with MAOIs, alcohol, or stimulants | MAOIs: dangerous potentiation. Alcohol: increased nausea, poor judgment. Stimulants: cardiovascular strain. |
| Resource | Contact | Purpose |
|---|---|---|
| 911 / Emergency | 911 | Life-threatening emergency |
| Poison Control (US) | 1-800-222-1222 | Overdose guidance, unknown substance identification |
| Fireside Project (psychedelic support) | 6-2FIRESIDE (623-473-7433) | Bad trip support, integration, non-emergency |
Educational Summary
2C-B pills are oral tablets containing the synthetic psychedelic 2C-B (4-bromo-2,5-dimethoxyphenethylamine). Effects last 4-8 hours with onset of 45-75 minutes. Common doses range from 5-25mg (10-15mg is typical starting dose). 2C-B produces a unique combination of stimulant, empathogenic (MDMA-like), and hallucinogenic (LSD-like) effects.
Safety: 2C-B has a steep dose-response curve — 5-10mg can be the difference between a mild and overwhelming experience. Pill potency varies significantly (5-25mg+). Always test pills with reagents (Marquis yellow→green) to rule out NBOMes (fatal) and other adulterants. Start with half a pill. Do not redose within 2-3 hours due to delayed onset (45-75 minutes). Avoid if personal/family history of psychosis.
Legal status: Schedule I/Class A controlled substance in most jurisdictions. Illegal to possess, sell, or distribute. No approved medical use.
Key dangers: NBOMe adulteration (fatal at milligram doses), unpredictable pill dosages, anxiety/panic attacks, HPPD (rare), psychosis (in predisposed individuals).
Note: This information is for educational and awareness purposes only. 2C-B is a Schedule I/Class A controlled substance with no accepted medical use. It is illegal to possess, sell, or distribute. Nothing here is medical advice or an endorsement of use. If you or someone you know is experiencing a medical emergency, call 911 immediately. If you need help for substance use, contact SAMHSA at 1-800-662-4357.
| Quantity (25mg) | 25 pills, 50 pills, 100 pills, 200 pills |
|---|




